1 Report Overview

1.1 Study Scope and Definition

1.2 Research Methodology

1.2.1 Methodology/Research Approach

1.2.2 Data Source

1.3 Key Market Segments

1.4 Players Covered: Ranking by Biologics and Biosimilars Revenue

1.5 Market Analysis by Type

1.5.1 Global Biologics and Biosimilars Market Size Growth Rate by Type: 2021 VS 2027

1.5.2 Monoclonal Antibodies

1.5.3 Interferon

1.5.4 Erythropoietin

1.5.5 Insulin

1.5.6 Vaccines

1.5.7 Other

1.6 Market by Application

1.6.1 Global Biologics and Biosimilars Market Share by Application: 2022-2027

1.6.2 Tumor

1.6.3 Diabetes

1.6.4 Cardiovascular

1.6.5 Hemophilia

1.6.6 Other

1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections

1.7.2 Covid-19 Impact: Commodity Prices Indices

1.7.3 Covid-19 Impact: Global Major Government Policy

1.8 Study Objectives

1.9 Years Considered

2 Global Biologics and Biosimilars Market Trends and Growth Strategy

2.1 Market Top Trends

2.2 Market Drivers

2.3 Market Challenges

2.4 Porters Five Forces Analysis

2.5 Market Growth Strategy

2.6 SWOT Analysis

3 Global Biologics and Biosimilars Market Players Profiles

3.1 Roche

3.1.1 Roche Company Profile

3.1.2 Roche Biologics and Biosimilars Product Specification

3.1.3 Roche Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.2 Eli Lilly

3.2.1 Eli Lilly Company Profile

3.2.2 Eli Lilly Biologics and Biosimilars Product Specification

3.2.3 Eli Lilly Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.3 Sanofi-Aventis

3.3.1 Sanofi-Aventis Company Profile

3.3.2 Sanofi-Aventis Biologics and Biosimilars Product Specification

3.3.3 Sanofi-Aventis Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.4 Amgen

3.4.1 Amgen Company Profile

3.4.2 Amgen Biologics and Biosimilars Product Specification

3.4.3 Amgen Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.5 Novo Nordisk

3.5.1 Novo Nordisk Company Profile

3.5.2 Novo Nordisk Biologics and Biosimilars Product Specification

3.5.3 Novo Nordisk Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.6 AbbVie

3.6.1 AbbVie Company Profile

3.6.2 AbbVie Biologics and Biosimilars Product Specification

3.6.3 AbbVie Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.7 Merck

3.7.1 Merck Company Profile

3.7.2 Merck Biologics and Biosimilars Product Specification

3.7.3 Merck Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.8 Pfizer

3.8.1 Pfizer Company Profile

3.8.2 Pfizer Biologics and Biosimilars Product Specification

3.8.3 Pfizer Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.9 Johnson & Johnson

3.9.1 Johnson & Johnson Company Profile

3.9.2 Johnson & Johnson Biologics and Biosimilars Product Specification

3.9.3 Johnson & Johnson Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.10 Novartis

3.10.1 Novartis Company Profile

3.10.2 Novartis Biologics and Biosimilars Product Specification

3.10.3 Novartis Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.11 Gelgen

3.11.1 Gelgen Company Profile

3.11.2 Gelgen Biologics and Biosimilars Product Specification

3.11.3 Gelgen Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.12 Ganlee

3.12.1 Ganlee Company Profile

3.12.2 Ganlee Biologics and Biosimilars Product Specification

3.12.3 Ganlee Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.13 3sbio

3.13.1 3sbio Company Profile

3.13.2 3sbio Biologics and Biosimilars Product Specification

3.13.3 3sbio Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.14 Innovent

3.14.1 Innovent Company Profile

3.14.2 Innovent Biologics and Biosimilars Product Specification

3.14.3 Innovent Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.15 Biotech

3.15.1 Biotech Company Profile

3.15.2 Biotech Biologics and Biosimilars Product Specification

3.15.3 Biotech Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.16 Changchun High Tech

3.16.1 Changchun High Tech Company Profile

3.16.2 Changchun High Tech Biologics and Biosimilars Product Specification

3.16.3 Changchun High Tech Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.17 Dong Bao

3.17.1 Dong Bao Company Profile

3.17.2 Dong Bao Biologics and Biosimilars Product Specification

3.17.3 Dong Bao Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.18 CP Guojian

3.18.1 CP Guojian Company Profile

3.18.2 CP Guojian Biologics and Biosimilars Product Specification

3.18.3 CP Guojian Biologics and Biosimilars Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Biologics and Biosimilars Market Competition by Market Players

4.1 Global Biologics and Biosimilars Production Capacity Market Share by Market Players (2016-2021)

4.2 Global Biologics and Biosimilars Revenue Market Share by Market Players (2016-2021)

4.3 Global Biologics and Biosimilars Average Price by Market Players (2016-2021)

5 Global Biologics and Biosimilars Production by Regions (2016-2021)

5.1 North America

5.1.1 North America Biologics and Biosimilars Market Size (2016-2021)

5.1.2 Biologics and Biosimilars Key Players in North America (2016-2021)

5.1.3 North America Biologics and Biosimilars Market Size by Type (2016-2021)

5.1.4 North America Biologics and Biosimilars Market Size by Application (2016-2021)

5.2 East Asia

5.2.1 East Asia Biologics and Biosimilars Market Size (2016-2021)

5.2.2 Biologics and Biosimilars Key Players in East Asia (2016-2021)

5.2.3 East Asia Biologics and Biosimilars Market Size by Type (2016-2021)

5.2.4 East Asia Biologics and Biosimilars Market Size by Application (2016-2021)

5.3 Europe

5.3.1 Europe Biologics and Biosimilars Market Size (2016-2021)

5.3.2 Biologics and Biosimilars Key Players in Europe (2016-2021)

5.3.3 Europe Biologics and Biosimilars Market Size by Type (2016-2021)

5.3.4 Europe Biologics and Biosimilars Market Size by Application (2016-2021)

5.4 South Asia

5.4.1 South Asia Biologics and Biosimilars Market Size (2016-2021)

5.4.2 Biologics and Biosimilars Key Players in South Asia (2016-2021)

5.4.3 South Asia Biologics and Biosimilars Market Size by Type (2016-2021)

5.4.4 South Asia Biologics and Biosimilars Market Size by Application (2016-2021)

5.5 Southeast Asia

5.5.1 Southeast Asia Biologics and Biosimilars Market Size (2016-2021)

5.5.2 Biologics and Biosimilars Key Players in Southeast Asia (2016-2021)

5.5.3 Southeast Asia Biologics and Biosimilars Market Size by Type (2016-2021)

5.5.4 Southeast Asia Biologics and Biosimilars Market Size by Application (2016-2021)

5.6 Middle East

5.6.1 Middle East Biologics and Biosimilars Market Size (2016-2021)

5.6.2 Biologics and Biosimilars Key Players in Middle East (2016-2021)

5.6.3 Middle East Biologics and Biosimilars Market Size by Type (2016-2021)

5.6.4 Middle East Biologics and Biosimilars Market Size by Application (2016-2021)

5.7 Africa

5.7.1 Africa Biologics and Biosimilars Market Size (2016-2021)

5.7.2 Biologics and Biosimilars Key Players in Africa (2016-2021)

5.7.3 Africa Biologics and Biosimilars Market Size by Type (2016-2021)

5.7.4 Africa Biologics and Biosimilars Market Size by Application (2016-2021)

5.8 Oceania

5.8.1 Oceania Biologics and Biosimilars Market Size (2016-2021)

5.8.2 Biologics and Biosimilars Key Players in Oceania (2016-2021)

5.8.3 Oceania Biologics and Biosimilars Market Size by Type (2016-2021)

5.8.4 Oceania Biologics and Biosimilars Market Size by Application (2016-2021)

5.9 South America

5.9.1 South America Biologics and Biosimilars Market Size (2016-2021)

5.9.2 Biologics and Biosimilars Key Players in South America (2016-2021)

5.9.3 South America Biologics and Biosimilars Market Size by Type (2016-2021)

5.9.4 South America Biologics and Biosimilars Market Size by Application (2016-2021)

5.10 Rest of the World

5.10.1 Rest of the World Biologics and Biosimilars Market Size (2016-2021)

5.10.2 Biologics and Biosimilars Key Players in Rest of the World (2016-2021)

5.10.3 Rest of the World Biologics and Biosimilars Market Size by Type (2016-2021)

5.10.4 Rest of the World Biologics and Biosimilars Market Size by Application (2016-2021)

6 Global Biologics and Biosimilars Consumption by Region (2016-2021)

6.1 North America

6.1.1 North America Biologics and Biosimilars Consumption by Countries

6.1.2 United States

6.1.3 Canada

6.1.4 Mexico

6.2 East Asia

6.2.1 East Asia Biologics and Biosimilars Consumption by Countries

6.2.2 China

6.2.3 Japan

6.2.4 South Korea

6.3 Europe

6.3.1 Europe Biologics and Biosimilars Consumption by Countries

6.3.2 Germany

6.3.3 United Kingdom

6.3.4 France

6.3.5 Italy

6.3.6 Russia

6.3.7 Spain

6.3.8 Netherlands

6.3.9 Switzerland

6.3.10 Poland

6.4 South Asia

6.4.1 South Asia Biologics and Biosimilars Consumption by Countries

6.4.2 India

6.5 Southeast Asia

6.5.1 Southeast Asia Biologics and Biosimilars Consumption by Countries

6.5.2 Indonesia

6.5.3 Thailand

6.5.4 Singapore

6.5.5 Malaysia

6.5.6 Philippines

6.6 Middle East

6.6.1 Middle East Biologics and Biosimilars Consumption by Countries

6.6.2 Turkey

6.6.3 Saudi Arabia

6.6.4 Iran

6.6.5 United Arab Emirates

6.7 Africa

6.7.1 Africa Biologics and Biosimilars Consumption by Countries

6.7.2 Nigeria

6.7.3 South Africa

6.8 Oceania

6.8.1 Oceania Biologics and Biosimilars Consumption by Countries

6.8.2 Australia

6.9 South America

6.9.1 South America Biologics and Biosimilars Consumption by Countries

6.9.2 Brazil

6.9.3 Argentina

6.10 Rest of the World

6.10.1 Rest of the World Biologics and Biosimilars Consumption by Countries

7 Global Biologics and Biosimilars Production Forecast by Regions (2022-2027)

7.1 Global Forecasted Production of Biologics and Biosimilars (2022-2027)

7.2 Global Forecasted Revenue of Biologics and Biosimilars (2022-2027)

7.3 Global Forecasted Price of Biologics and Biosimilars (2022-2027)

7.4 Global Forecasted Production of Biologics and Biosimilars by Region (2022-2027)

7.4.1 North America Biologics and Biosimilars Production, Revenue Forecast (2022-2027)

7.4.2 East Asia Biologics and Biosimilars Production, Revenue Forecast (2022-2027)

7.4.3 Europe Biologics and Biosimilars Production, Revenue Forecast (2022-2027)

7.4.4 South Asia Biologics and Biosimilars Production, Revenue Forecast (2022-2027)

7.4.5 Southeast Asia Biologics and Biosimilars Production, Revenue Forecast (2022-2027)

7.4.6 Middle East Biologics and Biosimilars Production, Revenue Forecast (2022-2027)

7.4.7 Africa Biologics and Biosimilars Production, Revenue Forecast (2022-2027)

7.4.8 Oceania Biologics and Biosimilars Production, Revenue Forecast (2022-2027)

7.4.9 South America Biologics and Biosimilars Production, Revenue Forecast (2022-2027)

7.4.10 Rest of the World Biologics and Biosimilars Production, Revenue Forecast (2022-2027)

7.5 Forecast by Type and by Application (2022-2027)

7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)

7.5.2 Global Forecasted Consumption of Biologics and Biosimilars by Application (2022-2027)

8 Global Biologics and Biosimilars Consumption Forecast by Regions (2022-2027)

8.1 North America Forecasted Consumption of Biologics and Biosimilars by Country

8.2 East Asia Market Forecasted Consumption of Biologics and Biosimilars by Country

8.3 Europe Market Forecasted Consumption of Biologics and Biosimilars by Countriy

8.4 South Asia Forecasted Consumption of Biologics and Biosimilars by Country

8.5 Southeast Asia Forecasted Consumption of Biologics and Biosimilars by Country

8.6 Middle East Forecasted Consumption of Biologics and Biosimilars by Country

8.7 Africa Forecasted Consumption of Biologics and Biosimilars by Country

8.8 Oceania Forecasted Consumption of Biologics and Biosimilars by Country

8.9 South America Forecasted Consumption of Biologics and Biosimilars by Country

8.10 Rest of the world Forecasted Consumption of Biologics and Biosimilars by Country

9 Global Biologics and Biosimilars Sales by Type (2016-2027)

9.1 Global Biologics and Biosimilars Historic Market Size by Type (2016-2021)

9.2 Global Biologics and Biosimilars Forecasted Market Size by Type (2022-2027)

10 Global Biologics and Biosimilars Consumption by Application (2016-2027)

10.1 Global Biologics and Biosimilars Historic Market Size by Application (2016-2021)

10.2 Global Biologics and Biosimilars Forecasted Market Size by Application (2022-2027)

11 Global Biologics and Biosimilars Manufacturing Cost Analysis

11.1 Biologics and Biosimilars Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.3 Manufacturing Process Analysis of Biologics and Biosimilars

12 Global Biologics and Biosimilars Marketing Channel, Distributors, Customers and Supply Chain

12.1 Marketing Channel

12.2 Biologics and Biosimilars Distributors List

12.3 Biologics and Biosimilars Customers

12.4 Biologics and Biosimilars Supply Chain Analysis

13 Analyst's Viewpoints/Conclusions

14 Disclaimer